Jun. 12 at 1:17 PM
$KRTL KRTL Holding Group Inc. (OTC: KRTL) today announced that its wholly owned subsidiary, KRTL Biotech Inc., has secured an initial purchase order valued at
$240,000 for Thiamine Mononitrate (Vitamin B1) and Riboflavin (Vitamin B2) through the efforts of its recently expanded sales leadership team.
https://www.otcmarkets.com/stock/KRTL/news/KRTL-Biotech-Inc-Advances-API-Supply-Chain-Strategy-with-240000-Initial-Purchase-Order?id=482627